Belgian (Chinese herb) nephropathy: Why?

Journal de Pharmacie de Belgique

Volumn 52, Issue 1, 1997, Pages 7-27

  Violon, C ^a  

^a Association Pharmaceutique Belge   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AMFEPRAMONE; AMINOPHYLLINE; AMPHETAMINE DERIVATIVE; ANOREXIGENIC AGENT; ANTIBIOTIC AGENT; ARISTOLOCHIC ACID; BELLADONNA ALKALOID; CASCARA; DEXFENFLURAMINE; HERBACEOUS AGENT; MAGNOLIA OFFICINALIS EXTRACT; MEPROBAMATE; STEPHANIA TETRANDRA EXTRACT; THEOPHYLLINE; UNCLASSIFIED DRUG;

CHINESE HERB; CYTOTOXICITY; DRUG ACTIVITY; DRUG USE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MUTAGENICITY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OBESITY; PHYTOCHEMISTRY; PHYTOTHERAPY; PRESCRIPTION; REVIEW;

ANTI-OBESITY AGENTS; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS;

EID: 0030938783     PISSN: 00472166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Vanherweghem J.L. , M. Depierreux, C. Tielemans, D. Abramowicz, M. Dratwa, M. Jadoul, C. Richard, D. Vandervelde, D. Verbeelen, R. Vanhaelen-Fastré & M. Vanthielen, Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs, The Lancet, 341 (1993) 387-391.
2. Cosyns J.P. , M. Jadoul, J.P. Squifflet, P.J. Van Congh, C. Van Ypersele de Strihou, Letters to the editor, Urothelial malignancy in nephropathy due to Chinese herbs, The Lancet, 344 (1994) 188.
3. Kabanda A., M. Jadoul, R. Lauwerys, A. Bernard and C. Van Ypersele de Strihou, Low molecular weight proteinuria in Chinese herbs nephropathy, Kidney International 48 (1995) 1571-1576.
4. Vanherweghem. J.L., C. Tielemans, J. Simon & M. Depierreux, Chinese herb nephropathy and renal pelvic carcinoma, Nephrol. Dial. Transplant 10 (1995) 270-273.
5. Cosyns J.P., M. Jadoul, J.P. Squifflet, J.F. De Plaen, D. Ferluga & C. Van Ypersele de Strihou, Chinese herbs nephropathy: A clue to Balkan endemic nephropathy?, Kidney International 45 (1994) 1680-1688.
6. Depierreux M., B. Van Damme, K. Vanden Houte, J.L. Vanherweghem, Pathologic Aspects of a newly described nephropathy related to the prolonged use of Chinese herbs, Am. J. Kidney Diseases 24 (1994) 172-180.
7. Van Ypersele de Strihou C. & J.L. Vanherweghem, Nephrol. Dial Transplant, The tragic paradigm of Chinese herb nephropathy. Edit. Comments, Nephrol Dial Transplant, 1995, 157-160.
8. Vanherweghem J.L. , D. Abramowicz, C. Tielemans and M. Depierreux, Effects on the progression of renal failure in chronic Interstitial Renal Fibrosis: A pilot study in Chinese herb nephropathy, Am. J. Kidney Diseases 27 (1996) 209-215.
9. Martindale, The Extra Pharmacopoeia, 29th Edition, Ed. J.E.F. Reynolds, Pharmaceutical Press, London, 1989.
10. Maeser B. , R. Snijder, B. Stricker, Pulmonale hypertensie na fenfluraminegebruik wegens overgewicht, Ned. Tijdschr. Geneesk. 138 (1994) 2500-2505.
11. Mc Cann U., G. Hatzidimitriou, A. Riderolt, C. Fischer, YJ. Yuan, J. Katz, G. Ricaurte, Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated, J. Pharmacol.Exp.Ther. 269 (1994) 792-798.
12. Mc Cann U., J. Yuan, G. Ricaurte, Fenfluramine's appetite suppression and neurotoxicity are separable, Eur. J. Pharmacol. 283 (1995) R5-7.
13. Thomas S. , A. butt, P. Corris, J. Egan, T. Higenbottam, B. Madden, P. Waller, Appetite suppressants and primary pulmonary hypertension in the United Kingdom, Br. Heart Journal 74/6 (1995) 660-663.
14. Cacoub P. , R. Dorent, R Nortaf, J.P. Houppe, P. Godeau, I. Gandjbakhch, Pulmonary hypertension and dexfenfluramine, Eur. J. Clin. Pharmacol. 48 (1995) 81-83.
15. Ferrari E. , E. Drai, J. Jourdan, B. Sanchez, M. Baudouy, P Morand, Severe pulmonary hypertension complicating a long treatment with dexfenfluramine, Arch. Mal. Coeur - Vaiss. 87 (1994) 285-286.
16. Brenot F. , R Herve, P. Petitpretz, F. Parent, R Duroux, G. Simmonneau, Primary pulmonary hypertension and fenfluramine use, Br. Heart J. 70 (1993) 537-541.
17. Pharmainformation 8, Nr. 2 (1993) uit «Kommentar zu Dexfenfluramin».
18. Goodman and Gilman's, The pharmacological Basis of Therapeutics (eight edition), Pergamon press (1990).
19. Répertoire commenté des médicaments, 1993, Centre Belge d'Information Pharmacothérapeutique.
20. Burny J.N., Ethylenediamine sensitivity with a systemic reaction to piperazine citrate, Contact Dermatitis 4 (1978) 380.
21. Textbook of adverse Drug reactions, D.M. Davies, Oxford, Oxford University Press (1977), p. 178, p. 319.
22. e edition, Visot (1982).
23. Moniteur des Pharmacies et Laboratoires No 2142 (4/1/95) p. 11.
24. Moniteur des Pharmacies et Laboratoires No 2122 (20/5/95) p. 8.
25. Advice of the «Gemeenschappelijke Commissie van de Academie voor Geneeskunde, Directeur Administration de l'Art de Guérir», 1982.
26. Pharmacopoeia of the People's Republic of China, English Ed. 1988
27. Tang & Eisenbrandt, Chinese Drugs of Plant Origin, Springer-Verlag, 1992.
28. The Merck Index on cd-ROM, version 12:1, 1996.
29. But PPH, K.L. Choi, Jin Bu Huan Anodyne tablets, a mislabeled and misclassified medecine, J. Hong Kong Med. Association 46 (1994) 302-305, (abstract from data-bank Drugs & Pharmacologie 1/95 - 12/95)
30. Zeng X.M., Martin G.P., Mariott C, Preparation and in vitro evaluation of tetrandrine-entrapped albumin microspheres as an inhaled drug delivery system, Eur. J. Pharm. Sci., 3/2 (1995) 87-93.
31. The Kidney, Brennor and Rector, fifth ed., 1996.
32. Cytotoxic and antimalarial bisbenzylisoquinoline alkaloids from Stephania erecta, Med. & Anat. Plants Abstr. 15(3) (1993) 264.
33. Penso G., Index plantarum medicinalium totius mundi eorumque synonymorum (1982).
34. Kupchan S. et al., Cytotoxicity of bisbenzylisoquinoline-alkaloid, J. Pharm. Sci. (april 1965).
35. Miles et al., Alterations in alveolar type II cell metabolism induced by tetrandrine and other alkaloids, Toxicol. Appl. Pharmacol., 119* (1993) 142-149.
36. Kondo Y, Tahano F., Hojo H., Inhibitory effect of bisbenzylisoquinoline alkaloids on nitric production in activated macrophages, Biochem. Pharmacol. 46 (1993) 1887-1892.
37. Hallard F., Phytothérapie, éd Masson, 1988.
38. Vandenbussche L, Onze volkstaal voor kruiden en artsenijen (1955), Menen, Belgium.
39. De Langhe J.F., L. Delvosalle, J. Dervigneaud, J. Lambinon, C. Vandenberghen, Nouvelle flore de la Belgique, du Grand Duché de Luxembourg, du Nord de la France et des Régions voisines (1978).
40. Reutter L. , Traité de matière médicale, 1923, Parijs.
41. Associated Press 12/04/95, FDA lists nine dangerous plants.
42. J. Pourrat, J.L. Montastruc, J.L. Lacombe, J.M. Cisterne, O. Rascol, Ph. Dumazer. La Presse Médicale, 19 nov. 1994, 23n No 36, p. 1669.
43. 50 Millions de consommateurs No 274, 1994, 83-84.
44. Hagers Handbuch der Pharmazeutischen Praxis, P.H. List and L. Hörhammer, Springer, Verlag (1979)
45. Pillans P, New Zealand Medical Journal, 108, 1995, 469.
46. Systematik des Pflanzenreichs, D. Frohne & V. Jensen, Gustav Fischer Verlag, Stuttgart (1973).
47. Planchon G. and E. Collier, Les Drogues simples d'origine végétale, Paris, 1894.
48. White M.I., Contact Dermatitis from ethylenediamine. Contact Dermatitis 4 (1978) 291-293.
49. Abt A., J. Oh, R. Huntington, K. Burkhart, Arch. Intern. Med. vol 155, 1995, 211.
50. Hager's Handbuch der Pharmazeutischen Praxis, R. Hansel, K. Keller, H. Rempler, G. Schneider, Springer Verlag, 1994.
51. Townson DH, Pate J.L., Regulation of prostaglandin synthetis by interleukin-1 b in cultured bovine uretral cells. Biol. Reprod. 51(3), 1994, 480-485 (Abstract).
52. Moreno J., Effect of aristolochic acid on arachidonic acid cascade and in vivo models of inflammation, Immunopharmacology, 26(1), 1993, 1-9.
53. Baloto N. et al., Ethylene diamine dermatitis. Contact dermatitis, 15 (1986) 263-265,
54. 32P-postlabeling in target and non-target organs of rats treated with aristolochic acid I, IARC.Sci.Publ. 124, 1993, 167-171.
55. Rosielli M.R., Laconi E., Rao P.M., Rajalakshmi S., Saram D.S., Induction of hepatic nodules in the rat by Aristolochic acid, Cancer Letters, 71, 1993, 83-87.
56. Schmeiser H., Bieler C.A., Wiessler M, Van Ypersele de Strihou C, Cosyns J.P., Detection of DNA Adducts formed by Aristolochic Acid in Renal Tissue from Patients with Chinese herbs Nephropathy, Cancer Res., 56, 1996, 2025-2028.
57. Mehes J, Decsi L, Varga F & Kovacs S., Selektive chemische Ausschaltung der Harnkanälchen. I. Ordnung bei Kaninchen, Arch. exp. Path. u. Pharmak. Bd 234, 1958, 548-565.
58. Mengs U. and C. Stotzem, Renal toxicity of aristolochic add in rats as an example of nephrotoxicity testing in routine toxicology, Arch. Toxicol., 67, 1993, 307-311.
59. Mengs U. and C. Stotzem, Toxicity of aristolochic acid - a subacute study in male rats. Med. Sci. Res., 20, 1992, 223-224.
60. Tanaka K. and H. Arita, Secretory phospholipase A2 inhibitors. Possible new anti-inflammaotry agents, Agents Actions (AAS) 46, suppl., 1995, 51-64 .
61. Broschard T., M. Wiessler, C.W. vor der Lieth and H.H. Schmeiser. Translesional synthesis on DNA-templates containing site - specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid, Carcinogenesis, 15, 1994, 2331-2340
62. Wiessler M., DNA-adducts of pyrrolizidine alkaloids, nitroimidazoles and aristolochic acid. IARC Sci.Publ., 125, 1994, 165-177.
63. Urbani, C.E., Urticarial reaction to ethylenediamine in aminophylline following mesotherapy. Contact dermatitis, 31 (1994) 198-199.
64. 32P postlabelling analysis using different chromatographic procedures. Carcinogenesis 15, 1994, 1187-1192.
65. Broschard H. , M. Wiessler, H.H. Schmeiser. Effect of site specifically located aristolochic acid DNA-adducts on in vitro DNA synthesis by human DNA polymerase-α. Cancer Lett. 98, 1995, 47-56.
66. Pezuto J.M., S.M. Swanson, W. Man, C. Che, G. Cordell and H.H.S. Fong., Evaluation of the mutagenic and cytostatic potential of aristolochic acid and several of its derivatives, Mutation Research 206, 1988, 447-454.
67. Mengs U, Klein M., Genotoxic effects of aristolochic acid in the mouse micronucleus test, Planta Medica, 54, 1988, 502-503 .
68. Götzl E. and O. Schimmer, Mutagenecity of Aristolochic Acids (I, II) and aristolochic acid I in new YG strains in Salmonella typhymurium highly sensitive to certain nitroamines, Mutagenesis, 8, 1993, 17-22.
69. Pistelli L., E. Nieri, A.R. Billia, A. Maisili, Chemical constituents of Aristolochia rigida and mutagenic activity of aristolochic acid IV, J. Nat. Products 56, 1993, 1605-1608.
70. De Smet P. in Adverse effects of herbal drugs; P. De Smet, K. Kleer, R. Hansel, R.F. Chandler, Berlin, Springer-Verlag (1992) 79-89.
71. M. Stiborova, E. Frei, H. Schmeiser and M. Wiessler, Cytochrome P-450 and Peroxidase and Peroxidase oxidize detoxication products of carcinogenic Aristolochic Acids (aristolactams) to reactive metabolites binding to DNA in vitro, accelerated communication, www, HPLC-sector, 1996.
72. Stefanovic V, Polenakovic M.H., Balkan Nephropathy, Kidney Disease beyond the Balkan Polemakovic, Am. J. Nephrol. 11 (1991) 1-11.
73. Clarke E.G.C., Isolation & Identification of drugs in pharmaceuticals, body fluids and post-mortem material, The Pharmaceutical Press, London, Vol. 1-Vol. 2, 1973.
74. Wagner H., Bladt S., Zgainski E.M., Dünschichtchromatografische Analyse von ArtzneiDrogen, Springer-Verlag, 1983.
75. Dharmananda S., An analysis of Chinese herb prescriptions for arthritis, Institute for Traditional Medicine, Arthritis, Portland, Oregon, 11 pages, www, Yahoo-search on «Stephania», 1996.
76. Handbuch der traditionellen Chinesischen heilpflanzen p 246, 1987.
77. Oriental materia medica, p 273-274.
78. The raintree Group, Inc., Austin, Texas 78757, raintree@bga.com, ABUTA , 1996.
79. Wang X. , Y. Zhao, T. Zhao and C. Che, Further constituents of Stephania sutchuensis, Planta Medica, 61, 1995, 99.
80. Thiele K., R.C. Muehrcke and H. Berning, Nierenerkrankungen durch Medikamente, Dtsche. med.Wschr. 92, 1987, 1632-1635.
81. Jackson L., S. Kofman, A. Weiss, H. Brodovsky, Aristolochic Acid (NSC-50413) Phase I clinical study, Cancer chemotherapy reports No 42, 1964, 35-37.
82. Poison Information Database, P. Gopalakrishnakone, Department of Anatomy, Faculty of Medecine, National University of Singapore, Kent Ridge Crescent, Singapore 0511, Atgopal@ leonis.nus.sg, www.
83. Rücker G. und R. Mayer; Bisbenzylisochinolinalkaloide aus den Wurzeln von Aristolochia debilis, Planta Medica x, 1985, 183-184.
84. Pharmacopeia of the People's Republic of China, 1988, General Notices.
85. Dharmananda S., Institute for traditional Medecine, Portland, Oregon, July 1996, www.
86. Van Haelen M., R. Van HaelenFastre, P. But, J.L. Vanherweghem, Identification of aristolochic acid in Chinese herbs, The Lancet, 343, 1994, 174.
87. R.D. Toto, Review acute tubulointerstitial Nefritis, The American Journal of the Medical Sciences, 299, 1990, 392-410.
88. Communiqué de presse - Conseil des ministres 12/12/96, Ministère de la Santé Publique, Bâtiment Amazone, Bd Bisschofsheim 33, 1000 Bruxelles.
89. DI, Rezepturarzneimittel zur Gewichtsreduktion, Pharm. Ztg, 132, 1987, 36.
90. T.P., Schlank und Krank auf rezept, Pharm. Ztg, 129, 1984, 2450.
91. Press articles on prescriptions of Dr. YC.
92. Chapuis G., Acide Aristolochique, Médecine et hygiène, 41, 1983, 15.
93. Contact dermatitis, 15, 1996, 263-265.
94. Diamond J., T. Pallone, Acute interstitial Nephritis following use of Tung Shueh Pills, Am. J. Kidney Diseases 24, 1994, 219-221.
95. Izumotani T., E. Ishimura, K. Tsumura, K. Goto, Y. Nishizawa, H. Morii, An adult case of Fanconi syndrome due to a mixture of Chinese crude drugs, Nephron, 65, 1993, 137-140.
96. Flora of China Genera, Vol. 7, «Sinomenium acutum», http://herbaria. harvard.edu/china/taxa/vol7.genera.htm
97. Yamamasaki H., Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum, Acta Med. Okayama 30, 1976, 1-20 uit Poisonous Plant Toxicity Bibliography, http:// vm.cfsan.fda-gov/djw/y.text.
98. Informations OMS Vol. 7 No 1993 Régimes amaigrissant à base de plantes et néphrotoxicité.
99. Segasothy M., Samad S.. Illicit herbal preparation containing phenylbutazone causing analgesic Nephropathy, Nephron, 59, 1991, 166-167.
100. R. Blackwell, Cases of Herb Toxicity, Adverse effects involving certain Chinese herbal medecines and the response of the profession, http:// accupuncture.com/Herbology/toxic.htm (8/12/96).
101. Depoorter A.M., Van Germeersch L., Chinese herbs and Renal function : an explorative study in a private practice of Chinese medecine (to publish).
102. Zum Zulassungswiderruf Aristolochiasaürhaltiger Fertigarzneimittel, Pharmazeutische Zeitung, 126, 1981, 1373.
103. GDM on Chinese plants on the market.
104. WHO publications, Pharmaceuticals, 1994, publicity for: WHO regional publications. Western Pacific Series No 2, Medicinal Plants in China, A selection of 150 commonly used species , 1989.
105. Bulletin du Conseil National, Ordre des Médecins, 1991, Décembre N° 54, 1991.
106. Wichtige mitteilungen der Arzneimittel Komission der Deutscher Apotheker. Redact., Dtsche. Apr. Ztg. 135, 1995, 3150-3152.
107. Redact., OAZ, 49, 1995, 892-893.
108. Bulletin du Conseil National, Ordre des Médecins, juin 1991 No 52.